Think Research to be acquired by lender Beedie Capital
The deal offers “the best available path forward” for the healthtech firm.
Healthtech
H|T: The Healthtech Times – Beleaguered 23andMe weighs splitting
Plus: Amazon makes cuts in healthcare units.
ZayZoon, Symend, Peggy named to CIX’s top early-stage, growth startup lists
This is the first edition of the lists since Elevate acquired CIX in September 2023.
Unbounce among the latest #CDNtech companies making changes at the top
WeCook, Aifred Health, and Stream Systems have also made leadership changes this month.
Fuelled by Well Health partnership, Healwell looks to apply AI to preventative care
Healwell AI zeroes in on M&A for growth after surgically removing its clinical footprint.
H|T: The Healthtech Times – Neuralink implants in first human test subject
Plus: How 23andMe’s valuation fell from $6 billion to nearly $0.
Northleaf Capital Partners completes final close of $285-million CAD growth equity fund
The technology and healthcare-focused fund surpassed its $269-million CAD target.
H|T: The Healthtech Times – $135M CBIV fund, Femtech Canada put women’s health in the spotlight
Plus: Tech chases ‘Plan A’ as demand for male fertility services grows.
AI-powered medical record reviewer Wisedocs closes $12.7-million CAD Series A round
Wisedocs claims it has more than doubled its customer base in 2023.
University of Calgary’s “venture philanthropy fund” UCeed targets pre-seed funding gap
Three and a half years since its launch, UCeed has grown into one of Canada’s most active early-stage investors.
H|T: The Healthtech Times – OMERS reportedly puts LifeLabs up for sale
Plus: PointClickCare’s acquisition spree continues with US healthtech company.
Femtech Canada officially launches network to support women’s health innovation
Network includes over 120 companies, industry partners, investors, accelerators.
CBIV surpasses $135 million CAD in final close to back women, children-focused healthtech startups
With Fund I, Toronto’s CBIV targets both market returns and impact.
TIAP partners with OBIO to open applications for healthtech funding stream
Selected companies will receive up to $200,000 in grant, dilutive funding.
H|T: The Healthtech Times – This DeepMind spin-off wants to cut drug discovery times in half
Plus: Clinia secures $10 million and partnership with Telus Health.